Article

Multiple factors determine residual refractive error

Attention to a host of preoperative and intraoperative factors can minimize the risk of residual refractive error after cataract surgery, but when a refractive surprise occurs, there are multiple variables to consider before deciding on intervention according to one expert.

According to national benchmarks, cataract surgeons should aim for the achieved refraction to be within 0.5 D of the target about 55% of the time and within 1.0 D in about 85% of cases.

Dr. Arbisser said that, in her hands and based on analysis of data for all comers, she well exceeds these targets with 85% of eyes achieving a refraction ±0.5 D of the target and 99.2% having a RRE <1.0 D.

Preventive strategies

"Although we cannot bill for this procedure, it may be worth obtaining an axial length measurement with [partial coherence interferometry] when patients present with early cataractous changes, even if surgery is not yet contemplated, just in case the patient does not return before the cataract becomes super dense," Dr. Arbisser said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.